This study elucidates the structural mechanism of HEP-50768, a novel MRGPRX4 inverse agonist, and demonstrates its potent anti-itch efficacy and favorable safety in preclinical models, positioning it as a promising therapeutic for chronic pruritus.
- Jun Yang
- Ruichao Shen
- Xiaoguang Lei